Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625] - 11/11/23
Doi : 10.1016/j.biopha.2023.115787
Tang Ziyang a, b, Hu Xirong c, An Chongming a, b, d, Li Tingxin a, b, d, ⁎ 
a Department of Health Management & Institute of Health Management, Sichuan Provincial People’s Hospital, Chengdu, PR China
b School of Medicine, University of Electronic Science and Technology of China, Chengdu, PR China
c Faculty of Nursing, Xi’an Jiaotong University, Xi’an, PR China
d Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, PR China
⁎Corresponding author at: Department of Health Management & Institute of Health Management, Sichuan Provincial People’s Hospital, Chengdu, PR China.Department of Health Management & Institute of Health Management, Sichuan Provincial People’s HospitalChengduPR China
Le texte complet de cet article est disponible en PDF.
© 2023
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 168
Article 115787- décembre 2023 Retour au numéro
Article précédent
- Corrigendum to “Protective effects of Punica granatum (pomegranate) peel extract on concanavalin A-induced autoimmune hepatitis in mice” [Biomed. Pharmacother. 100 (2018) 213–220]
- Tingting Wang, Ruoting Men, Mingxing Hu, Xiaoli Fan, Xiaoxue Yang, Xiaojun Huang, Tinghong Ye, Li Yang
- Retraction notice to "Long noncoding RNA TP73-AS1 promotes non-small cell lung cancer progression by competitively sponging miR-449a/EZH2" [Biomed. Pharmacother. 104 (2018) 705–711]
- Lin Zhang, Fengqi Fang, Xin He
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?